Emblaveo MDR Infections: Evaluating a New Solut...

By HEOR Staff Writer

November 18, 2025

Emblaveo Approved for MDR Gram-Negative Infections Emblaveo MDR infections pose a growing threat in Portugal, with the public assessment report evaluating Emblaveo (aztreonam + avib...
C. auris Outbreak in Europe: Alarming Spread and Rising Resistance
CAPVAXIVE Pneumococcal Vaccine Delivers Strong Immune Response in At-Risk Youth
Model Type and Its Impact on Pneumococcal Vaccine Cost-Effectiveness in Germany
PCV20 Reimbursement Guidelines: Analysis of Dutch Advisory Council Recommenda...
Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implic...
Hepatitis Vaccine Uptake: Trends, Challenges, and the Role of Pharmacists
VIETNARMS Trial Unveils Innovative Hepatitis C Treatment Options
Hepatitis C Investment Impact: Maximizing Health and Economic Returns in China
First At-Home HPV Testing Approval: FDA Clears Teal Wand
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control
HCV Treatment Advancements: Atea Pharmaceuticals KOL Panel
Assessing Risks and Opportunities: The Impact of the CDC Hepatitis Lab Closure